Lobular breast cancer is breast cancer that starts in the lobes where milk is made, and makes up about 10-15% of invasive breast cancer diagnoses. It is more difficult to detect and treat, and often metastasizes (spreads) to different organs than other breast cancers. Metastatic lobular breast cancer is currently treated the same way as other breast cancers. However, scientific research is showing how this cancer differs from the more common breast cancer (ductal) and that more clinical trials are needed for lobular breast cancer.
Click the links below to learn about Lobular Breast Cancer: general information, challenges in treatment, new research, resources and support, and clinical trials.
New Research in Lobular Breast Cancer
- Susan G Komen Advocates in Science: ILC and Its Complicated Relationship With the Estrogen Receptor
- Invasive Lobular Breast Cancer Symposium (videos): International Invasive Lobular Breast Cancer (ILC) Virtual Symposiums
- BCRF: Behind the Breakthroughs: Advancing Our Understanding of Invasive Lobular Breast Cancer (Dr. Steffi Oesterreich and patient advocate Leigh Pate)
- Oncologist 2021: Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer
General Information About Lobular Breast Cancer
- Lobular Breast Cancer Alliance
- Lobular Breast Cancer Alliance: LBCA Brochure with Information for Patients about Lobular Breast Cancer
- 2017 NW Metastatic Breast Cancer Conference: Lobular Breast Cancer 101: Fundamentals
- 2017 NW Metastatic Breast Cancer Conference: Lobular Breast Cancer 102: Metastasis & Clinical
- Diane Mapes: Lobular Breast Cancer Comes Into the Spotlight
- National Library of Medicine: Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast
Support for Lobular Breast Cancer
- Metastatic LBC Facebook Group: Support for People with Metastatic Lobular Breast Cancer
Clinical Trials for Lobular Breast Cancer
- Metastatic Trial Search Use MTS to Find Clinical Trials for Lobular Breast Cancer
Last Modified on April 11, 2024